statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	657
SG - Singapore	171
CN - Cina	126
HK - Hong Kong	62
BR - Brasile	58
VN - Vietnam	56
GB - Regno Unito	44
IT - Italia	36
FI - Finlandia	32
SE - Svezia	32
DE - Germania	25
KR - Corea	22
RU - Federazione Russa	22
FR - Francia	20
BD - Bangladesh	14
IN - India	9
NL - Olanda	9
LT - Lituania	8
MX - Messico	8
CA - Canada	7
ID - Indonesia	7
ZA - Sudafrica	7
BG - Bulgaria	6
PL - Polonia	6
EC - Ecuador	5
EG - Egitto	5
JP - Giappone	5
PH - Filippine	5
AE - Emirati Arabi Uniti	4
PE - Perù	4
TR - Turchia	4
CO - Colombia	3
CZ - Repubblica Ceca	3
ES - Italia	3
IQ - Iraq	3
RO - Romania	3
AR - Argentina	2
AT - Austria	2
CR - Costa Rica	2
DZ - Algeria	2
JM - Giamaica	2
KE - Kenya	2
LB - Libano	2
NP - Nepal	2
RS - Serbia	2
TH - Thailandia	2
TN - Tunisia	2
UZ - Uzbekistan	2
AL - Albania	1
AZ - Azerbaigian	1
BH - Bahrain	1
BO - Bolivia	1
CH - Svizzera	1
ET - Etiopia	1
GA - Gabon	1
GE - Georgia	1
GR - Grecia	1
HN - Honduras	1
IE - Irlanda	1
IL - Israele	1
JO - Giordania	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
MA - Marocco	1
ML - Mali	1
MY - Malesia	1
PA - Panama	1
PK - Pakistan	1
PT - Portogallo	1
PY - Paraguay	1
QA - Qatar	1
SK - Slovacchia (Repubblica Slovacca)	1
UA - Ucraina	1
VE - Venezuela	1
Totale	1.541

Nome	#
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon	272
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort	197
The epidemiology of hepatitis delta infection in Italy	191
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B	176
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination	171
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study	161
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications	152
Neutrophil–lymphocyte ratio is associated with worse outcomes in patients with cirrhosis: insights from the PRO-LIVER Registry	124
Molecular diagnostics in hepatitis C virus infection: Clinical applications	105
Totale	1.549

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	13	0	0	0	0	0	0	0	0	0	5	6	2
2021/2022	78	5	3	0	2	2	7	7	4	10	6	26	6
2022/2023	95	7	13	12	5	13	15	2	12	11	0	1	4
2023/2024	106	3	6	7	10	16	8	15	13	1	2	13	12
2024/2025	399	11	0	10	26	71	59	29	21	53	17	41	61
2025/2026	796	68	50	66	95	146	52	130	42	73	74	0	0
Totale													1.549